[Evidence on the key role of the metabotrobic glutamatergic receptors in the pathogenesis of schizophrenia: a "breakthrough" in pharmacological treatment].

MLA

Pannese, Rossella, et al. “[Evidence on the Key Role of the Metabotrobic Glutamatergic Receptors in the Pathogenesis of Schizophrenia: A ‘Breakthrough’ in Pharmacological Treatment].” Rivista Di Psichiatria, vol. 47, no. 2, Mar. 2012, pp. 149–69. EBSCOhost, https://doi.org/10.1708/1069.11719.

APA

Pannese, R., Minichino, A., Pignatelli, M., Delle Chiaie, R., Biondi, M., & Nicoletti, F. (2012). [Evidence on the key role of the metabotrobic glutamatergic receptors in the pathogenesis of schizophrenia: a “breakthrough” in pharmacological treatment]. Rivista Di Psichiatria, 47(2), 149–169. https://doi.org/10.1708/1069.11719

Chicago

Pannese, Rossella, Amedeo Minichino, Marco Pignatelli, Roberto Delle Chiaie, Massimo Biondi, and Ferdinando Nicoletti. 2012. “[Evidence on the Key Role of the Metabotrobic Glutamatergic Receptors in the Pathogenesis of Schizophrenia: A ‘Breakthrough’ in Pharmacological Treatment].” Rivista Di Psichiatria 47 (2): 149–69. doi:10.1708/1069.11719.